新发糖尿病相关足溃疡患者的死亡率:一项对管理具有启示的队列研究
该分析基于英格兰和威尔士国家糖尿病足护理审计中2017年4月至2022年3月注册的新发糖尿病相关足溃疡患者,评估12、26和52周死亡率及危险因素。71000例患者中,12、26和52周死亡率分别为4.2%、8.2%和14.4%;高龄、溃疡面积≥1 cm²、深溃疡、后足位置、下肢缺血及多种合并症与26周死亡率升高相关。作者认为应调整繁重的干预措施以最大化剩余生命质量,而非仅关注愈合。
要点
- 新发糖尿病相关足溃疡患者26周死亡率为8.2%,52周为14.4%。
- 年龄≥80岁、溃疡面积≥1 cm²、深溃疡、后足位置及下肢缺血与26周死亡率升高相关。
- 合并症如心力衰竭、心肌梗死、卒中、肾脏替代治疗及慢性肾脏病3期及以上与26周死亡率升高相关。
核心结论
- 糖尿病相关足溃疡患者短期死亡率高,管理团队应考虑调整繁重的干预和护理措施以最大化剩余生命质量,而非仅关注溃疡愈合。
研究设计与样本
- 基于英格兰和威尔士国家糖尿病足护理审计(NDFA)的队列研究,纳入2017年4月至2022年3月由专科糖尿病足护理服务注册的新发糖尿病相关足溃疡患者,采用泊松回归模型探索死亡危险因素。
主要发现
- 71000例新发糖尿病相关足溃疡患者中,12周死亡率为4.2%,26周为8.2%,52周为14.4%。
- 26周时,年龄≥80岁较65-79岁死亡率更高(率比2.15;95%CI 2.03,2.28)。
- 26周时,溃疡面积≥1 cm²(率比1.50;95%CI 1.42,1.59)、深溃疡(率比1.26;95%CI 1.18,1.35)、后足位置(率比1.53;95%CI 1.44,1.62)及下肢缺血证据(率比1.78;95%CI 1.69,1.88)与死亡率升高相关。
- 26周时,合并症与死亡率升高相关:心力衰竭(率比2.13;95%CI 2.00,2.26)、心肌梗死(率比1.45;95%CI 1.29,1.63)、卒中(率比1.37;95%CI 1.22,1.53)、肾脏替代治疗(率比2.34;95%CI 2.09,2.61)、慢性肾脏病3期及以上(率比1.20;95%CI 1.12,1.29)。
- 26周死亡率超过25%者占所有个体的7.3%,在65岁及以上者中升至11.5%,在80岁及以上者中升至22.1%。
临床怎么用
- 作者认为,管理糖尿病相关足溃疡患者的团队应考虑调整繁重的干预和护理措施以最大化剩余生命质量,而非仅关注溃疡愈合。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS/HYPOTHESIS: People with diabetes-related foot ulcers (DFUs) have high mortality rates. This analysis assesses the impact of selected risk factors on short-term mortality using a population registered in the National Diabetes Foot Care Audit (NDFA). METHODS: Mortality rates at 12, 26 and 52 weeks was assessed in people with a new DFU registered by a specialist diabetes footcare service in the NDFA in England and Wales between April 2017 and March 2022. Poisson regression models were created to explore risk factors for mortality. RESULTS: In 71,000 people registered with a new DFU, mortality rates at 12, 26 and 52 weeks was 4.2%, 8.2% and 14.4%, respectively. At 26 weeks, higher mortality rates was associated with older age (rate ratio 2.15; 95% CI 2.03, 2.28, for age ≥80 years vs age 65-79 years), certain ulcer characteristics (area ≥1 cm2 [1.50; 95% CI 1.42, 1.59], deep ulcers [1.26; 95% CI 1.18, 1.35] or hindfoot location [1.53; 95% CI 1.44, 1.62]) and recorded evidence of ischaemia in the lower limb (1.78; 95% CI 1.69, 1.88) and various comorbidities (heart failure [2.13; 95% CI 2.00, 2.26], myocardial infarction [1.45; 95% CI 1.29, 1.63], stroke [1.37; 95% CI 1.22, 1.53], renal replacement therapy [2.34; 95% CI 2.09, 2.61] and chronic kidney disease stage 3 or greater [1.20; 95% CI 1.12, 1.29]). The 26-week mortality rate exceeded 25% for 7.3% of all individuals, rising to 11.5% of those aged 65 years and older, and 22.1% of those aged 80 years and over. CONCLUSIONS/INTERPRETATION: Short-term mortality rates in people with a DFU is high. Teams managing people with DFUs should consider modifying the burdensome interventions and care required to heal such ulcers so maximising the quality of residual life, rather than focusing exclusively on healing.
引用
- Holman N, Yelland AC, Young B, et al. Mortality rates in people presenting with a new diabetes-related foot ulcer: a cohort study with implications for management. Diabetologia. 2024. PMID: 39331060. doi:10.1007/s00125-024-06262-w
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。